Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new two-year project funded by the UK Department for International Development (DFID) will strengthen training and delivery capacity for clubfoot treatment in sub-Saharan Africa.

Around 200,000 children born each year are affected by clubfoot, with 80% of these in low and middle income countries. Without treatment, the condition becomes ‘neglected clubfoot’, a painful and severely disabling deformity. However, in up to 95% of cases, clubfoot can be treated successfully using the Ponseti method of treatment, especially if this is initiated early.

A new two-year project funded by the UK Department for International Development (DFID) will strengthen training and delivery capacity for clubfoot treatment in sub-Saharan Africa. Starting in March 2015, the Africa Clubfoot Training (ACT) Project will support existing clubfoot treatment programmes through training a new cadre of national clubfoot trainers in 15 countries.

The ACT Project aims to strengthen partnerships between clubfoot service delivery partners within Ethiopia and across the region. A team of UK NHS, Ethiopian and regional African trainers will design and develop training materials for a standardised clubfoot provider and instructor course. The courses will be piloted in Ethiopia, bringing together senior clubfoot practitioners from across the region, including orthopaedic surgeons, physiotherapists and clinical officers, to review the new instructor course materials and to enhance their training.

In addition, the project aims to improve treatment for children with neglected clubfoot, and will review the outcomes of non-surgical treatment of this condition at CURE Ethiopia Children’s Hospital over two years.

Photo: Before and after treatment for clubfoot. 

The ACT Project is a partnership between the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences at the University of Oxford, CURE Ethiopia Children’s HospitalCURE ClubfootGlobal Clubfoot Initiative (GCI)CURE International UK and local ministries of health.

Scott Reichenbach, Operations Director for CURE Clubfoot, said of the project, “We are excited and grateful for the unique opportunity to bring together clubfoot leaders from across the region with a team from Oxford, GCI and CURE to design and develop a training tool that can be replicated across sub-Saharan Africa.  This grant provides an avenue to teach the Ponseti method throughout a region, bringing us closer to a day when children born with clubfoot no longer face a life of disability.”

This project is funded by the UK Department for International Development (DFID) through a Health Partnership Scheme grant awarded by Tropical Health Education Trust, for the benefit of UK and partner country health sectors.

 

Contact: Professor Chris Lavy
Email: actproject@ndorms.ox.ac.uk
Tel: 01865 737543

© Images courtesy of CURE Clubfoot

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.